Go here to see the original:
CRISPR Therapeutics Proposes New Appointment to the Board of Directors

Excerpt from:
SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants

Here is the original post:
Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board

See the rest here:
BlueSphere Bio Appoints Robert Keefe, Ph.D. as Chief Development Officer

Read more:
PROCEPT BioRobotics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022 and attend the 2022 Bank of America Healthcare Conference on...

Read more from the original source:
Sanofi - AGM 03.05.2022 - Availability of Preparatory Documents

Continue reading here:
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update

See the original post here:
ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting

See more here:
Finch Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates

Read more:
BioSyent Announces Grant of Restricted Share Units

Go here to see the original:
Avicanna Announces Closing of Non-Brokered Private Placement

See the article here:
T2 Biosystems Announces BARDA Exercise of Contract Option 2B Valued at $4.4 Million

Go here to read the rest:
Voluntary delisting of ADSs has become effective

Follow this link:
Theratechnologies to Announce Financial Results for Its First Quarter 2022

More here:
Avicanna Announces Filing of Annual Financial Statements for Year Ended December 31, 2021

Read more:
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2021 Financial Results

Go here to see the original:
Hyloris Successfully Raises EUR 15.0 Million in an Equity Offering by Means of A Private Placement Via an Accelerated Bookbuild Offering

Read the original post:
Mydecine Reports Financial Results for the Fiscal Year 2021 and Provides a Business Update

See the original post:
Freeline to Present on Its Fabry and Gaucher Disease AAV-Based Gene Therapies at the 18th Annual WORLDSymposium™

Read more:
Press Release: EUROAPI listing on Euronext Paris expected on May 6, 2022